AMAG Quote, Trading Chart, AMAG Pharmaceuticals Inc.

$13.75 Last:

0.15% Change Percent:

$13.75 Open:

$13.75 Previous Close:

$13.76 High:

$13.75 Low:

1,534,573 Volume:

11/13/2020 04:56:03 pm Last Trade Date Time:

Quotes are delayed by 15 to 20 minutes.

Stock Date	Open Price	Close Price	High	Low	Volume
2020-11-13	13.75	13.75	13.76	13.75	1,534,573
2020-11-12	13.73	13.73	13.75	13.72	2,903,338
2020-11-11	13.72	13.72	13.74	13.72	1,585,629
2020-11-10	13.71	13.73	13.73	13.71	1,485,559
2020-11-09	13.73	13.71	13.75	13.71	2,703,531
2020-11-06	13.71	13.72	13.73	13.7	659,070
2020-11-05	13.69	13.69	13.73	13.68	405,857
2020-11-04	13.66	13.72	13.72	13.66	1,010,658
2020-11-03	13.71	13.69	13.72	13.6101	2,313,886
2020-11-02	13.72	13.71	13.73	13.69	1,519,456
2020-10-30	13.69	13.72	13.73	13.69	861,529
2020-10-29	13.71	13.71	13.71	13.68	832,327
2020-10-28	13.69	13.71	13.74	13.6703	1,543,323
2020-10-27	13.68	13.7	13.71	13.68	730,168
2020-10-26	13.69	13.68	13.74	13.67	1,864,466
2020-10-23	13.65	13.67	13.67	13.61	713,047
2020-10-22	13.63	13.66	13.67	13.63	595,432
2020-10-21	13.66	13.63	13.67	13.61	748,366
2020-10-20	13.66	13.64	13.68	13.63	2,318,668
2020-10-19	13.64	13.64	13.65	13.61	1,068,964

Stock Information

AMAG Pharmaceuticals Inc. Company Name:

AMAG Stock Symbol:

NASDAQ Market:

AMAG Pharmaceuticals Inc. Website:

AMAG Quote, Trading Chart, AMAG Pharmaceuticals Inc.

Get AMAG Alerts

News, Short Squeeze, Breakout and More Instantly...

AMAG - AMAG Pharmaceuticals Files Submission in Response To the Food And Drug Administration's Notice of Opportunity for a Hearing and Proposal To Withdraw Approval of Makena® (hydroxyprogesterone caproate injection)

WALTHAM, Mass., Dec. 14, 2020 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. has submitted its response to the FDA’s Notice of Opportunity for a Hearing (“NOOH”) regarding the Agency’s proposal to withdraw approval for Makena—also referred to as 17-OHP...
AMAG - MGIC Investment & Halozyme Therapeutics Set to Join S&P MidCap 400; First Bancorp, The Geo Group & Mednax to Join S&P SmallCap 600

MGIC Investment & Halozyme Therapeutics Set to Join S&P MidCap 400; First Bancorp, The Geo Group & Mednax to Join S&P SmallCap 600 MGIC Investment & Halozyme Therapeutics Set to Join S&P MidCap 400; First Bancorp, The Geo Group & Mednax to Join S&...
AMAG - AMAG Pharmaceuticals Requests Hearing to Maintain Makena® (Hydroxyprogesterone Caproate Injection) as a Treatment Option for Clinically Indicated Pregnant Patients

WALTHAM, Mass., Oct. 14, 2020 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) announced today that it has formally requested a public hearing in response to the U.S. Food and Drug Administration’s (FDA) proposal to withdraw its approval of Makena ® , the only F...